A detailed history of Meridian Financial, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Meridian Financial, LLC holds 780 shares of UTHR stock, worth $267,220. This represents 0.18% of its overall portfolio holdings.

Number of Shares
780
Previous 1,000 22.0%
Holding current value
$267,220
Previous $230 Million 8.16%
% of portfolio
0.18%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$228.26 - $319.04 $50,217 - $70,188
-220 Reduced 22.0%
780 $248 Million
Q3 2023

Aug 13, 2024

SELL
$211.82 - $248.24 $25,418 - $29,788
-120 Reduced 10.71%
1,000 $226 Million
Q1 2023

Aug 13, 2024

BUY
$212.99 - $276.17 $238,548 - $309,310
1,120 New
1,120 $251 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $15.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Meridian Financial, LLC Portfolio

Follow Meridian Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Financial, LLC with notifications on news.